- PAH Fate and Exposure
- PAH Health Outcomes
- Predicting Toxicity of PAH Mixtures
- PAH Remediation and Transformations
- Virtual Lab Tours
- Sinnhuber Aquatic Research Laboratory Tour
- Publications & Citation
- Publications
- Citation for Publications
Author Info
Bisson WH
2017
Chlebowski AC, Garcia GR, Ladu JK, Bisson WH, Truong L, Simonich SL, Tanguay RL Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHs. Toxicol Sci 2017 PubMed PMC5414855
2015
Goodale BC, La Du JK, Tilton SC, Sullivan CM, Bisson WH, Waters KM, Tanguay RL Ligand-Specific Transcriptional Mechanisms Underlie Aryl Hydrocarbon Receptor-Mediated Developmental Toxicity of Oxygenated PAHs. Toxicol Sci 2015 PubMed PMC4612346
2014
Perkins A, Phillips J, Kerkvliet NI, Tanguay RL, Perdew G, Kolluri SK, Bisson WH A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain. Biology (Basel) 2014 PubMed PMC4280506
Gerlach CV, Das SR, Volz DC, Bisson WH, Kolluri SK, Tanguay RL Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafish. Aquat Toxicol 2014 PubMed PMC4090055
2012
Goodale BC, Ladu JK, Bisson WH, Janszen DB, Waters KM, Tanguay RL AHR2 mutant reveals functional diversity of aryl hydrocarbon receptors in zebrafish. PLoS One 2012 PubMed PMC3252317
2010
O'donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One 2010 PubMed PMC2948512